Matches in SemOpenAlex for { <https://semopenalex.org/work/W2012316291> ?p ?o ?g. }
- W2012316291 endingPage "717" @default.
- W2012316291 startingPage "709" @default.
- W2012316291 abstract "Metastatic renal-cell carcinoma (mRCC) is highly resistant to cytotoxic agents or hormones and is currently mainly treated with cytokine-based therapy. Transient responses and moderate survival advantages have been achieved in a subset of patients with these aspecific biological response modifiers. Side-effects are considerable, especially with high-dose interleukin (IL)-2. Efforts made in the field of specific immunotherapy have focused on optimization of dendritic cell vaccination and on administration of monoclonal antibodies, either cold (unconjugated) or hot (radioactively labeled). Furthermore, allogeneic bone marrow transplantation is able to induce remissions but, regrettably, is related to substantial morbidity and mortality. Neutralization of the biological activity of some immunosuppressive cytokines produced by RCC (IL-6 and tumor necrosis factor-alpha) with monoclonal antibodies is currently under investigation. Insights gained into the processes and pathways underlying carcinogenesis have led to the development of new treatment strategies. These treatments can be used for clear cell RCC, since they focus on blocking gene products that are upregulated by mutations in the von Hippel-Lindau gene. Specific strategies include anti-vascular endothelial growth factor monoclonal antibody (bevacizumab) or inhibition of its receptor kinases (oral SU11248 or PTK787), or targeting the Raf kinase pathway (by BAY 43-9006) or the mammalian target of rapamycin (mTOR) pathway (by CCI-779). Early clinical results are promising, but their place in the treatment of RCC has to be determined." @default.
- W2012316291 created "2016-06-24" @default.
- W2012316291 creator A5006807426 @default.
- W2012316291 creator A5015641705 @default.
- W2012316291 creator A5062519984 @default.
- W2012316291 creator A5090109552 @default.
- W2012316291 date "2005-08-01" @default.
- W2012316291 modified "2023-09-26" @default.
- W2012316291 title "Novel treatment strategies in clear-cell metastatic renal cell carcinoma" @default.
- W2012316291 cites W114418843 @default.
- W2012316291 cites W117475386 @default.
- W2012316291 cites W1515725948 @default.
- W2012316291 cites W1749022239 @default.
- W2012316291 cites W1880365120 @default.
- W2012316291 cites W1914396593 @default.
- W2012316291 cites W1928193662 @default.
- W2012316291 cites W1964988193 @default.
- W2012316291 cites W1967884480 @default.
- W2012316291 cites W1970314732 @default.
- W2012316291 cites W1971473979 @default.
- W2012316291 cites W1980013575 @default.
- W2012316291 cites W1981969796 @default.
- W2012316291 cites W1984400406 @default.
- W2012316291 cites W1985981664 @default.
- W2012316291 cites W1986332851 @default.
- W2012316291 cites W1986434780 @default.
- W2012316291 cites W1987029196 @default.
- W2012316291 cites W1988160732 @default.
- W2012316291 cites W1996509713 @default.
- W2012316291 cites W2000289316 @default.
- W2012316291 cites W2003192353 @default.
- W2012316291 cites W2008437720 @default.
- W2012316291 cites W2008932991 @default.
- W2012316291 cites W2011917251 @default.
- W2012316291 cites W2013453542 @default.
- W2012316291 cites W2013626842 @default.
- W2012316291 cites W2013647024 @default.
- W2012316291 cites W2016325900 @default.
- W2012316291 cites W2017121383 @default.
- W2012316291 cites W2019602861 @default.
- W2012316291 cites W2021256410 @default.
- W2012316291 cites W2031615027 @default.
- W2012316291 cites W2034322241 @default.
- W2012316291 cites W2046507292 @default.
- W2012316291 cites W2052550764 @default.
- W2012316291 cites W2053397495 @default.
- W2012316291 cites W2058554371 @default.
- W2012316291 cites W2060136712 @default.
- W2012316291 cites W2063941399 @default.
- W2012316291 cites W2072889365 @default.
- W2012316291 cites W2073352490 @default.
- W2012316291 cites W2075082022 @default.
- W2012316291 cites W2076424556 @default.
- W2012316291 cites W2083591461 @default.
- W2012316291 cites W2084557581 @default.
- W2012316291 cites W2086165177 @default.
- W2012316291 cites W2098136315 @default.
- W2012316291 cites W2098176107 @default.
- W2012316291 cites W2099938880 @default.
- W2012316291 cites W2100428890 @default.
- W2012316291 cites W2102648794 @default.
- W2012316291 cites W2102725664 @default.
- W2012316291 cites W2105937199 @default.
- W2012316291 cites W2106453307 @default.
- W2012316291 cites W2107168679 @default.
- W2012316291 cites W2111046889 @default.
- W2012316291 cites W2111778006 @default.
- W2012316291 cites W2113416338 @default.
- W2012316291 cites W2120129511 @default.
- W2012316291 cites W2122090581 @default.
- W2012316291 cites W2123914905 @default.
- W2012316291 cites W2125861971 @default.
- W2012316291 cites W2132550116 @default.
- W2012316291 cites W2140496726 @default.
- W2012316291 cites W2140765540 @default.
- W2012316291 cites W2141577422 @default.
- W2012316291 cites W2146853858 @default.
- W2012316291 cites W2147394591 @default.
- W2012316291 cites W2153491150 @default.
- W2012316291 cites W2163500695 @default.
- W2012316291 cites W2168966763 @default.
- W2012316291 cites W2171469612 @default.
- W2012316291 cites W2258529761 @default.
- W2012316291 cites W2312457084 @default.
- W2012316291 cites W2313899108 @default.
- W2012316291 cites W2326245275 @default.
- W2012316291 cites W2334694951 @default.
- W2012316291 cites W2340893063 @default.
- W2012316291 cites W2415587511 @default.
- W2012316291 cites W2526195531 @default.
- W2012316291 cites W2604430565 @default.
- W2012316291 cites W4298379398 @default.
- W2012316291 cites W93204923 @default.
- W2012316291 doi "https://doi.org/10.1097/01.cad.0000167901.58877.a3" @default.
- W2012316291 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16027518" @default.
- W2012316291 hasPublicationYear "2005" @default.
- W2012316291 type Work @default.
- W2012316291 sameAs 2012316291 @default.